Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $5.4M $318.2K $432.1K $1.2M $1.3M $7.7K $73.6K $55.4K
Accounts Receivable $6.5K $5.1K $11.8K $9.3K $26.6K $12.4K $19.2K $48.9K
Inventory — — — — — — — —
Total Current Assets $5.7M $401.9K $548.2K $1.3M $1.4M $81.7K $328.7K $195.8K
Property, Plant & Equipment $120.7K $9.5K $1.7K $8.7K $16.8K $20.0K $32.7K $23.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $60.2K $87.1K $13.1K — — — — —
Total Assets $6.1M $512.1K $567.1K $1.3M $1.4M $125.3K $370.0K $237.5K
Liabilities
Accounts Payable $736.9K $426.6K $852.0K $868.9K $2.5M $3.1M — —
Total Current Liabilities $1.5M $1.5M $1.8M $1.6M $3.6M $13.2M $11.8M $4.4M
Long-Term Debt — — — — — — — —
Total Liabilities $1.5M $1.6M $5.4M $3.1M $3.6M $13.2M $11.8M $4.4M
Stockholders' Equity
Retained Earnings $-75.6M $-68.5M $-62.6M $-59.2M $-56.6M $-45.6M $-42.2M $-33.4M
Total Stockholders' Equity $18.3M $-1.1M $-4.8M $-1.8M $-2.2M $-13.1M $-11.4M $-4.2M
← Newer Page 2 of 2 Older →